Streamline Begin Period Cash Flow vs Price Cash Flow Ratio Analysis
STRM Stock | USD 0.39 0.01 2.50% |
Streamline Health financial indicator trend analysis is much more than just breaking down Streamline Health prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Streamline Health is a good investment. Please check the relationship between Streamline Health Begin Period Cash Flow and its Price Cash Flow Ratio accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Streamline Health Solutions. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Begin Period Cash Flow vs Price Cash Flow Ratio
Begin Period Cash Flow vs Price Cash Flow Ratio Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Streamline Health Begin Period Cash Flow account and Price Cash Flow Ratio. At this time, the significance of the direction appears to have very week relationship.
The correlation between Streamline Health's Begin Period Cash Flow and Price Cash Flow Ratio is 0.26. Overlapping area represents the amount of variation of Begin Period Cash Flow that can explain the historical movement of Price Cash Flow Ratio in the same time period over historical financial statements of Streamline Health Solutions, assuming nothing else is changed. The correlation between historical values of Streamline Health's Begin Period Cash Flow and Price Cash Flow Ratio is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Begin Period Cash Flow of Streamline Health Solutions are associated (or correlated) with its Price Cash Flow Ratio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Price Cash Flow Ratio has no effect on the direction of Begin Period Cash Flow i.e., Streamline Health's Begin Period Cash Flow and Price Cash Flow Ratio go up and down completely randomly.
Correlation Coefficient | 0.26 |
Relationship Direction | Positive |
Relationship Strength | Very Weak |
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Price Cash Flow Ratio
Most indicators from Streamline Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Streamline Health current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Streamline Health Solutions. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. At this time, Streamline Health's Sales General And Administrative To Revenue is very stable compared to the past year. As of the 1st of June 2024, Enterprise Value is likely to grow to about 32.2 M, while Selling General Administrative is likely to drop about 8.3 M.
2021 | 2022 | 2023 | 2024 (projected) | Total Revenue | 17.4M | 24.9M | 22.6M | 19.1M | Depreciation And Amortization | 5.1M | 4.5M | 4.9M | 2.9M |
Streamline Health fundamental ratios Correlations
Click cells to compare fundamentals
Streamline Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Streamline Health fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 31.7M | 26.0M | 61.8M | 61.5M | 41.7M | 32.0M | |
Short Long Term Debt Total | 3.8M | 2.7M | 10.1M | 9.7M | 10.6M | 6.0M | |
Other Current Liab | 2.5M | 1.5M | 6.5M | 7.0M | 3.8M | 2.8M | |
Total Current Liabilities | 15.6M | 7.4M | 13.5M | 16.8M | 13.7M | 10.2M | |
Total Stockholder Equity | 16.0M | 17.5M | 34.0M | 35.5M | 18.8M | 15.7M | |
Property Plant And Equipment Net | 152K | 495K | 341K | 111K | 88K | 83.6K | |
Net Debt | 2.2M | 312K | 256K | 3.2M | 7.4M | 7.7M | |
Retained Earnings | (79.4M) | (79.1M) | (85.7M) | (97.0M) | (115.7M) | (109.9M) | |
Accounts Payable | 1.3M | 272K | 778K | 626K | 1.3M | 1.1M | |
Non Current Assets Total | 25.1M | 18.7M | 46.7M | 45.5M | 32.9M | 19.4M | |
Non Currrent Assets Other | 695K | 886K | 948K | 1.7M | 1.7M | 1.2M | |
Net Receivables | 4.0M | 3.1M | 4.7M | 8.7M | 5.0M | 5.1M | |
Common Stock Shares Outstanding | 22.7M | 30.2M | 42.8M | 49.3M | 56.5M | 59.3M | |
Liabilities And Stockholders Equity | 31.7M | 26.0M | 61.8M | 61.5M | 41.7M | 32.0M | |
Non Current Liabilities Total | 55K | 1.1M | 14.3M | 9.2M | 9.2M | 6.8M | |
Other Current Assets | 919K | 416K | 568K | 710K | 629K | 1.2M | |
Other Stockholder Equity | 95.1M | 96.3M | 119.2M | 132.0M | 133.9M | 140.6M | |
Total Liab | 15.6M | 8.5M | 27.8M | 26.0M | 22.9M | 16.6M | |
Total Current Assets | 6.6M | 7.3M | 15.1M | 16.0M | 8.8M | 12.7M | |
Short Term Debt | 3.8M | 1.7M | 454K | 785K | 1.5M | 1.2M | |
Cash | 1.6M | 2.4M | 9.9M | 6.6M | 3.2M | 5.6M | |
Cash And Short Term Investments | 1.6M | 2.4M | 9.9M | 6.6M | 3.2M | 5.6M | |
Property Plant And Equipment Gross | 152K | 495K | 341K | 357K | 379K | 360.1K | |
Other Liab | 55K | 130K | 4.6M | 271K | 311.7K | 296.1K | |
Other Assets | 695K | 886K | 948K | 1.7M | 1.5M | 1.0M | |
Common Stock Total Equity | 208K | 305K | 316K | 576K | 662.4K | 695.5K | |
Common Stock | 305K | 316K | 478K | 576K | 590K | 619.5K | |
Property Plant Equipment | 152K | 104K | 341K | 5.9M | 6.8M | 7.2M | |
Current Deferred Revenue | 8.0M | 3.9M | 5.8M | 8.4M | 7.1M | 6.8M | |
Intangible Assets | 8.7M | 6.6M | 22.3M | 20.6M | 17.9M | 13.0M | |
Inventory | 1.3M | 901K | 1.4M | 1.0 | 0.9 | 0.86 | |
Net Tangible Assets | (8.2M) | 208K | (11.4M) | (2.4M) | (2.7M) | (2.9M) | |
Retained Earnings Total Equity | (76.6M) | (79.4M) | (79.1M) | (97.0M) | (87.3M) | (91.7M) | |
Long Term Debt Total | 3.9M | 3.4M | 989K | 9.0M | 8.1M | 5.4M | |
Capital Surpluse | 82.5M | 95.1M | 96.3M | 132.0M | 151.8M | 89.1M | |
Deferred Long Term Liab | 55K | 130K | 806K | 167K | 150.3K | 142.8K |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Streamline Health using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Streamline Health Solutions. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Complementary Tools for Streamline Stock analysis
When running Streamline Health's price analysis, check to measure Streamline Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Streamline Health is operating at the current time. Most of Streamline Health's value examination focuses on studying past and present price action to predict the probability of Streamline Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Streamline Health's price. Additionally, you may evaluate how the addition of Streamline Health to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |
Is Streamline Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Streamline Health. If investors know Streamline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Streamline Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 12.131 | Earnings Share (0.33) | Revenue Per Share 0.4 | Quarterly Revenue Growth (0.01) | Return On Assets (0.11) |
The market value of Streamline Health is measured differently than its book value, which is the value of Streamline that is recorded on the company's balance sheet. Investors also form their own opinion of Streamline Health's value that differs from its market value or its book value, called intrinsic value, which is Streamline Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Streamline Health's market value can be influenced by many factors that don't directly affect Streamline Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Streamline Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Streamline Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Streamline Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.